Skip to content
CVE Ledger
  • Newest CVEsPage
  • Recently added to KEVPage
  • Rising exploitation (EPSS)Page
  • Weekly digestPage
  • StatisticsPage
  • WatchlistPage
  • API docsPage
  • MCP serverPage
  • AboutPage
  • Data sourcesPage
  • Data statusPage
  • ChangelogPage
  • How it's builtPage
  • Support the projectPage

14 results

Back

CVE-2025-50675GPMAW 14, a bioinformatics software, has a critical vulnerability related to insecure file permissions in its installation directory. The…

Description

GPMAW 14, a bioinformatics software, has a critical vulnerability related to insecure file permissions in its installation directory. The directory is accessible with full read, write, and execute permissions for all users, allowing unprivileged users to manipulate files within the directory, including executable files like GPMAW3.exe, Fragment.exe, and the uninstaller GPsetup64_17028.exe. An attacker with user-level access can exploit this misconfiguration by replacing or modifying the uninstaller (GPsetup64_17028.exe) with a malicious version. While the application itself runs in the user's context, the uninstaller is typically executed with administrative privileges when an administrator attempts to uninstall the software. By exploiting this flaw, an attacker could gain administrative privileges and execute arbitrary code in the context of the admin, resulting in privilege escalation.

Public exploit

An exploit or proof of concept is public: anyone can try it against an unpatched system. A reference of the record is tagged as an exploit. CISA's SSVC rates its exploitation: a proof of concept is public.

Show the exploits1

Timeline

  1. ID reserved

    By mitre

  2. · 52 days later

    Published

  3. · 1 day later

    Record updated

Changes after publication (a new score, a public exploit, EPSS crossing 1, 10 or 50 %, leaving KEV) are kept since November 2026; earlier ones are not known.

Scores

CVSS scores of CVE-2025-50675, by who scored it
Scored byCVSSScoreVector
CISA-ADPADP (enrichment)3.1High7.8CVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
NVDNVD · Deferred3.1High7.8CVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H
EPSS (exploitation in 30 days)
0.26% · top 82% of all CVEs (17 Nov 2026)
CISA SSVC
Exploitation: poc · Automatable: no · Technical impact: total
Loading the EPSS history…

The list uses the assigner's score when there is one, then CISA's, then NVD's: High 7.8.

Affected products

  • n/a

    • affected n/a

References

References2

Sources

The same CVE in the primary databases and aggregators, to check against.

Badge for a README or a ticket

CVE-2025-50675 badge
[![CVE-2025-50675](https://cveledger.app/badge/CVE-2025-50675.svg)](https://cveledger.app/cve/CVE-2025-50675)

Record last updated .